Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia [Phase 4]
Phase 4 clinical trial evaluating rasburicase for prevention and treatment of hyperuricemia in pediatric patients with non-Hodgkin's lymphom…
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies [Phase 3]
Phase 3 clinical trial update on stem cell transplantation from partially HLA-m matched related donors for hematologic malignancies; trial c…
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome [Phase 1, Phase 2]
First-in-human dose-escalation study of SAR440234 in acute leukemia and myelodysplastic syndrome was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia [Phase 1]
Phase 1 trial evaluating S1312 (inotuzumab ozogamicin) with combination chemotherapy in adults with relapsed or refractory acute leukemias; …
-
CLINICAL_TRIALS trial_result · 2022-03-28Clinical Trial Update: Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT [Phase 1, Phase 2]
This clinical trial evaluates the safety and efficacy of γδ T cell therapy after allogeneic hematopoietic stem cell transplantation in hemat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: Study of Efficacy and Safety of Flumatinib Combined With Chemotherapy in Ph Positive ALL [Phase 3]
Phase 3 trial evaluating efficacy and safety of flumatinib in combination with chemotherapy for Philadelphia chromosome-positive acute lymph…
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase [Phase 3]
Phase 3 trial evaluating safety and effectiveness of apixaban to prevent blood clots in children with leukemia and a central venous catheter…
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 clinical trial evaluating ponatinib in combination with chemotherapy for young adults with Philadelphia chromosome-positive acute ly…
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: Total Therapy Study XVI for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia [Phase 3]
Phase 3 clinical trial update for Total Therapy Study XVI in newly diagnosed acute lymphoblastic leukemia, with results posted.
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic Leukemia [Phase 2, Phase 3]
Phase 2/3 clinical trial update for GRASPA (erythrocyte-encapsulated L-asparaginase) in relapsed acute lymphoblastic leukemia; results have …
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: Protocol For the Treatment Acute Lymphoblastic Leukemia With Ph 'Negative in Elderly Patients (> 55 Years) [Phase 4]
A Phase 4 trial update for treating Philadelphia-negative acute lymphoblastic leukemia in elderly patients (>55) is in an unknown status.
-
CLINICAL_TRIALS trial_result · 2022-01-19Clinical Trial Update: PETHEMA LAL-07FRAIL: All Treatment In Fragile Patients Ph' Negative Over 55 Years [Phase 4]
A Phase 4 clinical trial update for frail, Philadelphia-negative patients over 55 with acute lymphoblastic leukemia.
-
CLINICAL_TRIALS trial_result · 2022-01-18Clinical Trial Update: Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD [Phase 4]
A Phase 4 clinical trial evaluating the efficacy of bortezomib for relapsed acute lymphoblastic leukemia and related chemotherapeutic toxici…
-
CLINICAL_TRIALS trial_result · 2022-01-04Clinical Trial Update: Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic Leukemia [Phase 4]
Phase 4 trial evaluating the effect of simvastatin on sepsis and febrile neutropenia in patients with acute lymphoblastic leukemia.
-
CLINICAL_TRIALS trial_result · 2022-01-04Clinical Trial Update: Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 trial evaluating feasibility and effectiveness of inotuzumab ozogamicin in B-cell acute lymphoblastic leukemia.
-
CLINICAL_TRIALS trial_result · 2022-01-04Clinical Trial Update: Nalbuphine Versus Ketamine for Prevention of Emergence Agitation After Sevoflurane in Children Undergoing Tonsillectomy [Phase 4]
Phase 4 clinical trial comparing nalbuphine to ketamine for prevention of emergence agitation after sevoflurane in children undergoing tonsi…
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Double Cord Versus Haploidentical (BMT CTN 1101) [Phase 3]
Phase 3 trial comparing double cord blood transplantation versus haploidentical transplant in acute leukemias completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement [Phase 2]
Phase 2 trial evaluating azacitidine with combination chemotherapy in infants with KMT2A-rearranged acute lymphoblastic leukemia and related…
-
CLINICAL_TRIALS trial_result · 2021-10-04Clinical Trial Update: Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia [Phase 2]
Phase 2 trial update on a targeted therapy for relapsed/refractory acute lymphoblastic leukemia and acute myeloid leukemia; trial status ter…
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft [Phase 2, Phase 3]
Phase 2/Phase 3 evaluation of a donor testing kit to predict acute graft-versus-host disease in patients receiving peripheral blood stem cel…
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL [Phase 3]
Phase 3 trial for Marqibo in adults 60+ with newly diagnosed acute lymphoblastic leukemia was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-22Clinical Trial Update: An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia [Phase 2]
An extension Phase 2 trial evaluating the safety and anti-leukemic effects of imatinib mesylate in adults with Ph+ leukemias has completed a…
-
CLINICAL_TRIALS trial_result · 2021-07-21Clinical Trial Update: Phase III B in Acute Lymphoblastic Leukemia [Phase 3]
Phase III trial in Acute Lymphoblastic Leukemia completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia [NA]
Clinical trial update on high-throughput drug sensitivity assay and genomics-guided treatment for relapsed or refractory acute leukemia; stu…
-
CLINICAL_TRIALS trial_result · 2021-06-23Clinical Trial Update: A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy [Phase 2]
Phase 2 trial update on intravenous Erwinaze for patients with allergy to frontline asparaginase therapy in acute lymphoblastic leukemia or …